Clinical trials
Completed Bacterial Infections trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
147 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 2 |
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 5 |
| 2006 | 6 |
| 2007 | 9 |
| 2008 | 4 |
| 2009 | 5 |
| 2010 | 4 |
| 2011 | 4 |
| 2012 | 5 |
| 2013 | 11 |
| 2014 | 11 |
| 2015 | 8 |
| 2016 | 11 |
| 2017 | 12 |
| 2018 | 7 |
| 2019 | 6 |
| 2020 | 5 |
| 2021 | 8 |
| 2022 | 5 |
| 2023 | 4 |
| 2024 | 3 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 147 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 15 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 14 |
| Qpex Biopharma, Inc. | 7 |
| Pfizer | 5 |
| Duke University | 4 |
| Evopoint Biosciences Inc. | 4 |
| Melinta Therapeutics, Inc. | 4 |
| Tetraphase Pharmaceuticals, Inc | 4 |
| Debiopharm International SA | 3 |
| Forest Laboratories | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bacterial Infections | 147 |
| Infections | 15 |
| Cellulitis | 9 |
| HIV Infections | 7 |
| Abscess | 5 |
| Mycoses | 5 |
| Pneumonia | 5 |
| Skin Diseases, Bacterial | 5 |
| Surgical Wound Infection | 5 |
| Acquired Immunodeficiency Syndrome | 4 |
Trials
Showing 1 to 25 of 147. Each trial links to its page on Pharma Observatory.
47 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.